Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Teicher

Showing results (61-70 of 417) with videos related to

Pageof 42
Sort By:
Journal of Medicinal Chemistry|August 1, 1980
Nitrobenzyl halides and carbamates as prototype bioreductive alkylating agentsB A Teicher, A C Sartorelli
IEEE Transactions on Bio-Medical Engineering|January 1, 1978
Comparison of a dynamic and steady-state model for determining nerve fiber thresholdD A Teicher, D R McNeal
Expert Opinion on Therapeutic Targets|August 21, 2025
Rare tumors, real targets: patient-derived models for the discovery and validation of precision therapiesNathan P Coussens, Beverly A Teicher
Harefuah|August 1, 1981
[Labetalol in resistant hypertension]N Stern, A Teicher, T Rosenthal
The New England Journal of Medicine|November 9, 2012
The promise of antibody-drug conjugatesBeverly A Teicher, James H Doroshow
Biochemical and Biophysical Research Communications|August 29, 1978
Effects of adrenal steroid activator protein on the conversion of various 20- and 22-hydroxycholesterols to pregnenolone by adrenal mitochondrial enzymesB A Teicher, M Shikita, P Talalay
Anticancer Research|November 1, 1996
Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cellsG Chen, B A Teicher, E Frei
Cancer Chemotherapy and Pharmacology|October 29, 2000
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agentsK Lu, C Shih, B A Teicher
International Journal of Group Psychotherapy|April 1, 1974
Group psychotherapy and the intense group experience: a preliminary rationale for encounter as a therapeutic agent in the mental health fieldA Teicher, L de Freitas, A Osherson
The Lancet. Oncology|June 15, 2016
Antibody-drug conjugates for cancer therapyAnish Thomas, Beverly A Teicher, Raffit Hassan
Pageof 42

Showing results (61-70 of 417) with videos related to

Sort By:
Pageof 42
Journal of Medicinal Chemistry|August 1, 1980
Nitrobenzyl halides and carbamates as prototype bioreductive alkylating agentsB A Teicher, A C Sartorelli
IEEE Transactions on Bio-Medical Engineering|January 1, 1978
Comparison of a dynamic and steady-state model for determining nerve fiber thresholdD A Teicher, D R McNeal
Expert Opinion on Therapeutic Targets|August 21, 2025
Rare tumors, real targets: patient-derived models for the discovery and validation of precision therapiesNathan P Coussens, Beverly A Teicher
Harefuah|August 1, 1981
[Labetalol in resistant hypertension]N Stern, A Teicher, T Rosenthal
The New England Journal of Medicine|November 9, 2012
The promise of antibody-drug conjugatesBeverly A Teicher, James H Doroshow
Biochemical and Biophysical Research Communications|August 29, 1978
Effects of adrenal steroid activator protein on the conversion of various 20- and 22-hydroxycholesterols to pregnenolone by adrenal mitochondrial enzymesB A Teicher, M Shikita, P Talalay
Anticancer Research|November 1, 1996
Differential interactions of Pgp inhibitor thaliblastine with adriamycin, etoposide, taxol and anthrapyrazole CI941 in sensitive and multidrug-resistant human MCF-7 breast cancer cellsG Chen, B A Teicher, E Frei
Cancer Chemotherapy and Pharmacology|October 29, 2000
Expression of pRB, cyclin/cyclin-dependent kinases and E2F1/DP-1 in human tumor lines in cell culture and in xenograft tissues and response to cell cycle agentsK Lu, C Shih, B A Teicher
International Journal of Group Psychotherapy|April 1, 1974
Group psychotherapy and the intense group experience: a preliminary rationale for encounter as a therapeutic agent in the mental health fieldA Teicher, L de Freitas, A Osherson
The Lancet. Oncology|June 15, 2016
Antibody-drug conjugates for cancer therapyAnish Thomas, Beverly A Teicher, Raffit Hassan
Pageof 42